From April 22, 2022 to June 30, 2022, the company has repurchased 256,700 shares, representing 0.15% for CNY 4.86 million. With this, the company has completed the repurchase of 256,700 shares, representing 0.15% for CNY 4.86 million under the buyback announced on April 22, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.71 CNY | -0.92% |
|
-1.22% | -32.85% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.85% | 218M | |
-5.17% | 6.98B | |
+21.62% | 3.59B | |
-3.06% | 3.15B | |
+13.18% | 1.67B | |
-7.81% | 1.19B | |
-34.91% | 1.08B | |
-36.76% | 1.05B | |
-32.83% | 875M | |
-17.45% | 861M |
- Stock Market
- Equities
- 300871 Stock
- News Hvsen Biotechnology Co., Ltd.
- Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.